SCHEMBL30422682

SCHEMBL30422682

CCCOc1nc(N2CCN(C(=O)OC(C)(C)C)CC2)ncc1C(=O)Nc1cc(F)c2nn(C)cc2c1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ PTPN11 Q06124 5/20 0.49
▸ GPR119 Q8TDV5 5/20 0.41
▸ TP53 P04637 1/20 0.38
▸ THRB P10828 1/20 0.37
▸ HSD11B1 P28845 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ ACHE P22303 1/20 0.36
▸ RXFP1 Q9HBX9 1/20 0.36
▸ SCD O00767 1/20 0.35
▸ SCD5 Q86SK9 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31148362 1.00 PTPN11 (0.49) PTPN11GPR119TP53THRBHSD11B1
SCHEMBL25214352 0.94 PTPN11 (0.51) PTPN11GPR119TP53THRBMEN1
SCHEMBL30422842 0.92 PTPN11 (0.50) PTPN11GPR119TP53THRBMEN1
SCHEMBL30421627 0.91 PTPN11 (0.49) PTPN11GPR119TP53THRBMEN1
SCHEMBL31485467 0.86 HSD11B1 (0.40) PTPN11HSD11B1MAPT
SCHEMBL25438924 0.84 PTPN11 (0.50) PTPN11GPR119TP53MEN1MAPT
SCHEMBL30423069 0.84 PTPN11 (0.50) PTPN11GPR119TP53MEN1MAPT
SCHEMBL25210578 0.84 PTPN11 (0.45) PTPN11MAPT
SCHEMBL25211423 0.83 PTPN11 (0.39) PTPN11TP53MAPT
SCHEMBL30422643 0.83 PTPN11 (0.39) PTPN11TP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4441042-A1 5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND METHODS OF USING THE SAME Rgenta Therapeutics, Inc. (US) 2024-10-09 — — EP disclosed
WO-2023102231-A1 5-PYRIMIDINECARBOXAMIDE DERIVATIVES AND METHODS OF USING THE SAME RGENTA THERAPEUTICS, INC. (US) 2023-06-08 — — WO disclosed
Send feedback